{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:26:39Z","timestamp":1781864799304,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00417-025-06797-7","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:52:46Z","timestamp":1742424766000},"page":"1813-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intravitreal Dexamethasone Implant in Vitreoretinal Surgery: An Overview of the Literature"],"prefix":"10.1007","volume":"263","author":[{"given":"Giacomo","family":"Boscia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Oliva","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermete","family":"Giancipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Mastropasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"2","key":"6797_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2165\/11530970-000000000-00000","volume":"27","author":"N Kuno","year":"2010","unstructured":"Kuno N, Fujii S (2010) Biodegradable intraocular therapies for retinal disorders: progress to date. Drugs Aging 27(2):117\u2013134. https:\/\/doi.org\/10.2165\/11530970-000000000-00000","journal-title":"Drugs Aging"},{"key":"6797_CR2","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2147\/OPTH.S79948","volume":"9","author":"PU Dugel","year":"2015","unstructured":"Dugel PU, Bandello F, Loewenstein A (2015) Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol 9:1321\u20131335. https:\/\/doi.org\/10.2147\/OPTH.S79948","journal-title":"Clin Ophthalmol"},{"key":"6797_CR3","doi-asserted-by":"publisher","unstructured":"Feo A et al (2024) Peripapillary pachychoroid syndrome treated with dexamethasone implant: a case report. Eur J Ophthalmol: 11206721241254132. https:\/\/doi.org\/10.1177\/11206721241254132","DOI":"10.1177\/11206721241254132"},{"issue":"10","key":"6797_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.18240\/ijo.2021.10.15","volume":"14","author":"P Neves","year":"2021","unstructured":"Neves P et al (2021) Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes. Int J Ophthalmol 14(10):1571\u20131580. https:\/\/doi.org\/10.18240\/ijo.2021.10.15","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"6797_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ajo.2015.04.025","volume":"160","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA et al (2015) Pro-Permeability factors after dexamethasone implant in retinal vein occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) study. Am J Ophthalmol 160(2):313-321.e19. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.025","journal-title":"Am J Ophthalmol"},{"key":"6797_CR6","doi-asserted-by":"publisher","unstructured":"Iovino C et al (2020) Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature. Pharmaceutics 12(8). https:\/\/doi.org\/10.3390\/pharmaceutics12080703","DOI":"10.3390\/pharmaceutics12080703"},{"issue":"5","key":"6797_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9051556","volume":"9","author":"V Bonfiglio","year":"2020","unstructured":"Bonfiglio V et al (2020) Preoperative, intraoperative and postoperative corticosteroid use as an adjunctive treatment for rhegmatogenous retinal detachment. J Clin Med 9(5):1\u201329. https:\/\/doi.org\/10.3390\/jcm9051556","journal-title":"J Clin Med"},{"key":"6797_CR8","doi-asserted-by":"publisher","first-page":"6627677","DOI":"10.1155\/2021\/6627677","volume":"2021","author":"G Parisi","year":"2021","unstructured":"Parisi G et al (2021) Intravitreal dexamethasone implant for postoperative macular oedema secondary to vitrectomy for epiretinal membrane and retinal detachment: a systematic review and meta-analysis. J Ophthalmol 2021:6627677. https:\/\/doi.org\/10.1155\/2021\/6627677","journal-title":"J Ophthalmol"},{"issue":"6","key":"6797_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/IAE.0000000000001720","volume":"38","author":"A Thanos","year":"2018","unstructured":"Thanos A et al (2018) Dexamethasone intravitreal implant for the treatment of recalcitrant macular edema after rhegmatogenous retinal detachment repair. Retina 38(6):1084\u20131090. https:\/\/doi.org\/10.1097\/IAE.0000000000001720","journal-title":"Retina"},{"issue":"4","key":"6797_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000464259","volume":"237","author":"L-O Hattenbach","year":"2017","unstructured":"Hattenbach L-O et al (2017) Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica 237(4):232\u2013237. https:\/\/doi.org\/10.1159\/000464259","journal-title":"Ophthalmologica"},{"key":"6797_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5832186","volume":"2018","author":"Y-C Chang","year":"2018","unstructured":"Chang Y-C et al (2018) Dexamethasone intravitreal implant (Ozurdex) for long-term macular edema after epiretinal membrane peeling surgery. J Ophthalmol 2018:5832186. https:\/\/doi.org\/10.1155\/2018\/5832186","journal-title":"J Ophthalmol"},{"issue":"6","key":"6797_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4103\/ijo.IJO_1045_19","volume":"68","author":"SS Sane","year":"2020","unstructured":"Sane SS, Ali MH, Kuppermann BD, Narayanan R (2020) Comparative study of pars plana vitrectomy with or without intravitreal dexamethasone implant for idiopathic epiretinal membrane. Indian J Ophthalmol 68(6):1103\u20131107. https:\/\/doi.org\/10.4103\/ijo.IJO_1045_19","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"6797_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40942-023-00489-2","volume":"9","author":"MV Rodrigues","year":"2023","unstructured":"Rodrigues MV, Garcia JMB, Pacheco KD, Borges FT, Isaac DLC, Avila M (2023) Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant. Int J Retina Vitreous 9(1):56. https:\/\/doi.org\/10.1186\/s40942-023-00489-2","journal-title":"Int J Retina Vitreous"},{"key":"6797_CR14","doi-asserted-by":"publisher","unstructured":"Celik N,  Khoramnia R,  Auffarth GU,  Sel S,  Mayer CS (2020) Complications of dexamethasone implants: risk factors, prevention, and clinical management. Int J Ophthalmol 13(10):1612\u20131620.  https:\/\/doi.org\/10.18240\/ijo.2020.10.16","DOI":"10.18240\/ijo.2020.10.16"},{"issue":"2","key":"6797_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/S41433-020-1114-7","volume":"35","author":"V Raman","year":"2021","unstructured":"Raman V, Triggol A, Cudrnak T, Konstantinos P (2021) Safety of nurse-led intravitreal injection of dexamethasone (Ozurdex) implant service. Audit of first 1000 cases. Eye (Lond) 35(2):388\u2013392. https:\/\/doi.org\/10.1038\/S41433-020-1114-7","journal-title":"Eye (Lond)"},{"key":"6797_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejpb.2018.02.034","volume":"127","author":"S Stein","year":"2018","unstructured":"Stein S, Auel T, Kempin W, Bogdahn M, Weitschies W, Seidlitz A (2018) Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d, l-lactide-co-glycolide) or polycaprolactone. Eur J Pharm Biopharm 127:270\u2013278. https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.034","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"6797_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/1566524014666140128114414","volume":"14","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang N, Schachat AP, Bao S, Gillies MC (2014) Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema. Curr Mol Med 14(3):376\u2013384. https:\/\/doi.org\/10.2174\/1566524014666140128114414","journal-title":"Curr Mol Med"},{"issue":"1","key":"6797_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.17-22259","volume":"59","author":"SM Whitcup","year":"2018","unstructured":"Whitcup SM, Cidlowski JA, Csaky KG, Ambati J (2018) Pharmacology of corticosteroids for diabetic macular edema. Invest Ophthalmol Vis Sci 59(1):1\u201312. https:\/\/doi.org\/10.1167\/iovs.17-22259","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"6797_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/aos.13294","volume":"95","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S et al (2017) Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Acta Ophthalmol 95(5):464\u2013471. https:\/\/doi.org\/10.1111\/aos.13294","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"6797_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1167\/iovs.10-5285","volume":"52","author":"J-E Chang-Lin","year":"2011","unstructured":"Chang-Lin J-E et al (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52(1):80\u201386. https:\/\/doi.org\/10.1167\/iovs.10-5285","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6797_CR21","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2147\/DDDT.S138922","volume":"11","author":"V Bonfiglio","year":"2017","unstructured":"Bonfiglio V et al (2017) Widening use of dexamethasone implant for the treatment of macular edema. Drug Des Devel Ther 11:2359\u20132372. https:\/\/doi.org\/10.2147\/DDDT.S138922","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"6797_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/bjophthalmol-2016-308544","volume":"101","author":"D Bellocq","year":"2017","unstructured":"Bellocq D et al (2017) Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol 101(3):333\u2013341. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308544","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"6797_CR23","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/aos.14516","volume":"99","author":"M Fallico","year":"2021","unstructured":"Fallico M et al (2021) Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study. Acta Ophthalmol 99(1):e74\u2013e80. https:\/\/doi.org\/10.1111\/aos.14516","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"6797_CR24","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.5301\/ejo.5000599","volume":"25","author":"V Bonfiglio","year":"2015","unstructured":"Bonfiglio V et al (2015) Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling. Eur J Ophthalmol 25(5):e98\u2013e100. https:\/\/doi.org\/10.5301\/ejo.5000599","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"6797_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.oret.2016.11.001","volume":"1","author":"MA Zapata","year":"2017","unstructured":"Zapata MA et al (2017) Prevalence of vitreoretinal interface abnormalities on spectral-domain OCT in healthy participants over 45 years of age. Ophthalmol Retina 1(3):249\u2013254. https:\/\/doi.org\/10.1016\/j.oret.2016.11.001","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"6797_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ophtha.2014.10.014","volume":"122","author":"SM Meuer","year":"2015","unstructured":"Meuer SM et al (2015) The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology 122(4):787\u2013795. https:\/\/doi.org\/10.1016\/j.ophtha.2014.10.014","journal-title":"Ophthalmology"},{"issue":"12","key":"6797_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3928\/23258160-20241111-01","volume":"55","author":"A Sharma","year":"2024","unstructured":"Sharma A et al (2024) RWC update: uveal effusion syndrome; peeling the internal limiting membrane in epiretinal membrane surgery; partially scrambled best disease. Ophthalmic Surg Lasers Imaging Retina 55(12):689\u2013692. https:\/\/doi.org\/10.3928\/23258160-20241111-01","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"6797_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3109\/08820538.2010.544237","volume":"26","author":"CJ Pournaras","year":"2011","unstructured":"Pournaras CJ, Emarah A, Petropoulos IK (2011) Idiopathic macular epiretinal membrane surgery and ILM peeling: anatomical and functional outcomes. Semin Ophthalmol 26(2):42\u201346. https:\/\/doi.org\/10.3109\/08820538.2010.544237","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"6797_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/IAE.0b013e3181ac23da","volume":"29","author":"L Konstantinidis","year":"2009","unstructured":"Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ (2009) Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane. Retina 29(8):1119\u20131127. https:\/\/doi.org\/10.1097\/IAE.0b013e3181ac23da","journal-title":"Retina"},{"issue":"2","key":"6797_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajo.2005.01.033","volume":"140","author":"MW Johnson","year":"2005","unstructured":"Johnson MW (2005) Tractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol 140(2):184\u2013192. https:\/\/doi.org\/10.1016\/j.ajo.2005.01.033","journal-title":"Am J Ophthalmol"},{"key":"6797_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajo.2019.12.010","volume":"212","author":"A Govetto","year":"2020","unstructured":"Govetto A et al (2020) Distinctive mechanisms and patterns of exudative versus tractional intraretinal cystoid spaces as seen with multimodal imaging. Am J Ophthalmol 212:43\u201356. https:\/\/doi.org\/10.1016\/j.ajo.2019.12.010","journal-title":"Am J Ophthalmol"},{"key":"6797_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.635101","volume":"12","author":"M Fallico","year":"2021","unstructured":"Fallico M et al (2021) Epiretinal membrane vitrectomy with and without intraoperative intravitreal dexamethasone implant: a systematic review with meta-analysis. Front Pharmacol 12:635101. https:\/\/doi.org\/10.3389\/fphar.2021.635101","journal-title":"Front Pharmacol"},{"issue":"6","key":"6797_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/02713683.2019.1697454","volume":"45","author":"A Hostovsky","year":"2020","unstructured":"Hostovsky A, Muni RH, Eng KT, Mulhall D, Leung C, Kertes PJ (2020) Intraoperative dexamethasone intravitreal implant (Ozurdex) in vitrectomy surgery for epiretinal membrane. Curr Eye Res 45(6):737\u2013741. https:\/\/doi.org\/10.1080\/02713683.2019.1697454","journal-title":"Curr Eye Res"},{"issue":"5","key":"6797_CR34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/IAE.0000000000001627","volume":"38","author":"G Guidi","year":"2018","unstructured":"Guidi G et al (2018) Residual intraretinal edema afTER 25-GAUGE VITRECTOMY AND MACULAR PUCKER REMOVAL: Is Intraoperative Sustained-release Dexamethasone a Real Treatment Option? Retina 38(5):993\u2013999. https:\/\/doi.org\/10.1097\/IAE.0000000000001627","journal-title":"Retina"},{"issue":"2","key":"6797_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00417-020-04911-5","volume":"259","author":"A Savastano","year":"2021","unstructured":"Savastano A et al (2021) Evaluation of intraoperative slow-release dexamethasone implant combined with idiopathic epiretinal membrane removal. Graefes Arch Clin Exp Ophthalmol 259(2):379\u2013385. https:\/\/doi.org\/10.1007\/s00417-020-04911-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"6797_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","volume":"58","author":"W Kiddee","year":"2013","unstructured":"Kiddee W et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58(4):291\u2013310. https:\/\/doi.org\/10.1016\/j.survophthal.2012.08.003","journal-title":"Surv Ophthalmol"},{"key":"6797_CR37","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/DDDT.S229031","volume":"13","author":"C Iovino","year":"2019","unstructured":"Iovino C et al (2019) Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane. Drug Des Devel Ther 13:4107\u20134114. https:\/\/doi.org\/10.2147\/DDDT.S229031","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"6797_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12886-024-03312-0","volume":"24","author":"Z Nie","year":"2024","unstructured":"Nie Z et al (2024) Changes in optical coherence tomography biomarkers in eyes with advanced idiopathic epiretinal membrane treated with dexamethasone implantation. BMC Ophthalmol 24(1):54. https:\/\/doi.org\/10.1186\/s12886-024-03312-0","journal-title":"BMC Ophthalmol"},{"key":"6797_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2021.09.002","volume":"235","author":"E Borrelli","year":"2022","unstructured":"Borrelli E et al (2022) Long-term visual outcomes and morphologic biomarkers of vision loss in eyes with diabetic macular edema treated with Anti-VEGF therapy. Am J Ophthalmol 235:80\u201389. https:\/\/doi.org\/10.1016\/j.ajo.2021.09.002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6797_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40662-021-00252-4","volume":"8","author":"L Iuliano","year":"2021","unstructured":"Iuliano L, Cisa di Gresy G, Fogliato G, Corbelli E, Bandello F, Codenotti M (2021) Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes. Eye Vis (Lond) 8(1):29. https:\/\/doi.org\/10.1186\/s40662-021-00252-4","journal-title":"Eye Vis (Lond)"},{"key":"6797_CR41","doi-asserted-by":"publisher","unstructured":"Baldascino A et al (2024) Microvascular changes after epiretinal membrane vitrectomy with intraoperative intravitreal dexamethasone implant: an OCT angiography analysis. Diagnostics (Basel) 14(4). https:\/\/doi.org\/10.3390\/diagnostics14040411","DOI":"10.3390\/diagnostics14040411"},{"key":"6797_CR42","doi-asserted-by":"publisher","unstructured":"Liao L, Zhu XH (2019) Advances in the treatment of rhegmatogenous retinal detachment. Int J Ophthalmol 12(4):660\u2013667.  https:\/\/doi.org\/10.18240\/ijo.2019.04.22","DOI":"10.18240\/ijo.2019.04.22"},{"issue":"4","key":"6797_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/a-2040-3598","volume":"240","author":"C Neuhaus","year":"2023","unstructured":"Neuhaus C, Valmaggia C (2023) Postoperative results in the treatment of retinal detachment with scleral buckling surgery. Klin Monbl Augenheilkd 240(4):481\u2013485. https:\/\/doi.org\/10.1055\/a-2040-3598","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"6797_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3928\/23258160-20230508-03","volume":"54","author":"M Karam","year":"2023","unstructured":"Karam M et al (2023) Pneumatic retinopexy versus pars plana vitrectomy for rhegmatogenous retinal detachment: systematic review and meta-analysis. Ophthalmic Surg Lasers Imaging Retina 54(6):354\u2013361. https:\/\/doi.org\/10.3928\/23258160-20230508-03","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"11","key":"6797_CR45","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.oret.2023.07.010","volume":"7","author":"R Shor","year":"2023","unstructured":"Shor R, Melo IM, Motekalem Y, Zajner C, Muni RH (2023) Pneumatic retinopexy for rhegmatogenous retinal detachment in elderly patients. Ophthalmol Retina 7(11):959\u2013964. https:\/\/doi.org\/10.1016\/j.oret.2023.07.010","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"6797_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217548","volume":"14","author":"N Josifovska","year":"2019","unstructured":"Josifovska N et al (2019) Clinical and molecular markers in retinal detachment-from hyperreflective points to stem cells and inflammation. PLoS One 14(6):e0217548. https:\/\/doi.org\/10.1371\/journal.pone.0217548","journal-title":"PLoS One"},{"key":"6797_CR47","doi-asserted-by":"publisher","unstructured":"Watanabe A, Ishida M, Takeyama A, Ichikawa Y, Mizushima A, Imamura Y (2022) Surgical success rate of scleral buckling surgery and postoperative incidence of cystoid macular edema: 10 years of experience at a single academic hospital. J Clin Med 11(18). https:\/\/doi.org\/10.3390\/jcm11185321","DOI":"10.3390\/jcm11185321"},{"key":"6797_CR48","doi-asserted-by":"publisher","unstructured":"Reibaldi  M et al (2013) Rhegmatogenous retinal detachment with a high risk of proliferative vitreoretinopathy treated with episcleral surgery and an intravitreal dexamethasone 0.7-mg implant. Switzerland.  https:\/\/doi.org\/10.1159\/000351176","DOI":"10.1159\/000351176"},{"issue":"4","key":"6797_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1055\/s-0042-122384","volume":"234","author":"M Sherif","year":"2017","unstructured":"Sherif M, Wolfensberger TJ (2017) Intraocular dexamethasone implant as adjunct to silicone oil tamponade for proliferative vitreoretinopathy. Klin Monbl Augenheilkd 234(4):501\u2013504. https:\/\/doi.org\/10.1055\/s-0042-122384","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"6797_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2017.01.021","volume":"124","author":"PJ Banerjee","year":"2017","unstructured":"Banerjee PJ et al (2017) Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective randomized controlled clinical trial. Ophthalmology 124(6):757\u2013767. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.021","journal-title":"Ophthalmology"},{"issue":"10","key":"6797_CR51","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00592-019-01357-y","volume":"56","author":"M Iglicki","year":"2019","unstructured":"Iglicki M et al (2019) TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION study. Acta Diabetol 56(10):1141\u20131147. https:\/\/doi.org\/10.1007\/s00592-019-01357-y","journal-title":"Acta Diabetol"},{"issue":"1","key":"6797_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18240\/ijo.2023.01.04","volume":"16","author":"Y-M Zhao","year":"2023","unstructured":"Zhao Y-M et al (2023) Intravitreal slow-release dexamethasone alleviates traumatic proliferative vitreoretinopathy by inhibiting persistent inflammation and M\u00fcller cell gliosis in rabbits. Int J Ophthalmol 16(1):22\u201332. https:\/\/doi.org\/10.18240\/ijo.2023.01.04","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"6797_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12886-019-1094-1","volume":"19","author":"AR Cho","year":"2019","unstructured":"Cho AR, Yoon YH (2019) Adjunctive dexamethasone implant in patients with atopic dermatitis and retinal detachment undergoing vitrectomy and silicone oil tamponade: an interventional case series. BMC Ophthalmol 19(1):86. https:\/\/doi.org\/10.1186\/s12886-019-1094-1","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"6797_CR54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/jop.2021.0072","volume":"38","author":"U Limon","year":"2022","unstructured":"Limon U, Sezgin Ak\u00e7ay BI (2022) Efficacy of intravitreal dexamethasone after combined phacoemulsification and pars plana vitrectomy for diabetic tractional retinal detachments. J Ocul Pharmacol Ther 38(2):176\u2013182. https:\/\/doi.org\/10.1089\/jop.2021.0072","journal-title":"J Ocul Pharmacol Ther"},{"key":"6797_CR55","doi-asserted-by":"publisher","unstructured":"Orski M, Gaw\u0119cki M (2021) Current management options in irvine-gass syndrome: a systemized review. J Clin Med 10(19).  https:\/\/doi.org\/10.3390\/jcm10194375","DOI":"10.3390\/jcm10194375"},{"issue":"1","key":"6797_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-020-00254-9","volume":"7","author":"C Pole","year":"2021","unstructured":"Pole C, Chehaibou I, Govetto A, Garrity S, Schwartz SD, Hubschman JP (2021) Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses. Int J Retina Vitreous 7(1):1\u201310. https:\/\/doi.org\/10.1186\/s40942-020-00254-9","journal-title":"Int J Retina Vitreous"},{"key":"6797_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/971758","volume":"2013","author":"V Romano","year":"2013","unstructured":"Romano V et al (2013) Inflammation and macular oedema after pars plana vitrectomy. Mediators Inflamm 2013:971758. https:\/\/doi.org\/10.1155\/2013\/971758","journal-title":"Mediators Inflamm"},{"issue":"8","key":"6797_CR58","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.ophtha.2009.02.008","volume":"116","author":"SJ Kim","year":"2009","unstructured":"Kim SJ et al (2009) Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology 116(8):1531\u20131537. https:\/\/doi.org\/10.1016\/j.ophtha.2009.02.008","journal-title":"Ophthalmology"},{"issue":"1","key":"6797_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000496705","volume":"242","author":"I Chatziralli","year":"2019","unstructured":"Chatziralli I, Dimitriou E, Theodossiadis G, Chatzirallis A, Kazantzis D, Theodossiadis P (2019) Treatment of macular edema after pars plana vitrectomy for idiopathic epiretinal membrane using intravitreal dexamethasone implant: long-term outcomes. Ophthalmologica 242(1):16\u201321. https:\/\/doi.org\/10.1159\/000496705","journal-title":"Ophthalmologica"},{"issue":"1","key":"6797_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/09273948.2019.1652330","volume":"29","author":"I Chatziralli","year":"2021","unstructured":"Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P (2021) Macular edema after successful pars plana vitrectomy for rhegmatogenous retinal detachment: factors affecting edema development and considerations for treatment. Ocul Immunol Inflamm 29(1):187\u2013192. https:\/\/doi.org\/10.1080\/09273948.2019.1652330","journal-title":"Ocul Immunol Inflamm"},{"key":"6797_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3946531","volume":"2020","author":"S Freissinger","year":"2020","unstructured":"Freissinger S et al (2020) Evaluation of functional outcomes and OCT-biomarkers after intravitreal dexamethasone implant for postoperative cystoid macular edema in vitrectomized eyes. J Ophthalmol 2020:3946531. https:\/\/doi.org\/10.1155\/2020\/3946531","journal-title":"J Ophthalmol"},{"issue":"3","key":"6797_CR62","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JWY Yau","year":"2012","unstructured":"Yau JWY et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"issue":"1","key":"6797_CR63","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41598-023-30432-2","volume":"13","author":"E Borrelli","year":"2023","unstructured":"Borrelli E et al (2023) Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema. Sci Rep 13(1):3224. https:\/\/doi.org\/10.1038\/s41598-023-30432-2","journal-title":"Sci Rep"},{"issue":"6","key":"6797_CR64","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"JA Wells","year":"2016","unstructured":"Wells JA et al (2016) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 123(6):1351\u20131359. https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.022","journal-title":"Ophthalmology"},{"issue":"1","key":"6797_CR65","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/bjophthalmol-2019-313991","volume":"104","author":"B Rajesh","year":"2020","unstructured":"Rajesh B et al (2020) Safety of 6000 intravitreal dexamethasone implants. Br J Ophthalmol 104(1):39\u201346. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-313991","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"6797_CR66","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00592-019-01305-w","volume":"56","author":"YH Jung","year":"2019","unstructured":"Jung YH, Lee Y (2019) Efficacy of vitrectomy combined with an intraoperative dexamethasone implant in refractory diabetic macular edema. Acta Diabetol 56(6):691\u2013696. https:\/\/doi.org\/10.1007\/s00592-019-01305-w","journal-title":"Acta Diabetol"},{"issue":"6","key":"6797_CR67","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/IAE.0000000000002546","volume":"39","author":"P Carpineto","year":"2019","unstructured":"Carpineto P, Ciciarelli V, Borrelli E, Aharrh-Gnama A, Mastropasqua R (2019) Epiretinal membrane in eyes with vitreomacular traction. Retina 39(6):1061\u20131065. https:\/\/doi.org\/10.1097\/IAE.0000000000002546","journal-title":"Retina"},{"issue":"3","key":"6797_CR68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000443751","volume":"235","author":"DH Lee","year":"2016","unstructured":"Lee DH, Kim YJ, Yoon YH (2016) Minimally invasive microincision vitrectomy surgery with an intraoperative dexamethasone implant for refractory diabetic macular edema. Ophthalmologica 235(3):150\u2013156. https:\/\/doi.org\/10.1159\/000443751","journal-title":"Ophthalmologica"},{"issue":"3","key":"6797_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3341\/kjo.2018.0100","volume":"33","author":"KT Kim","year":"2019","unstructured":"Kim KT, Jang JW, Kang SW, Chae JB, Cho K, Bae K (2019) Vitrectomy combined with intraoperative dexamethasone implant for the management of refractory diabetic macular edema. Korean J Ophthalmol 33(3):249\u2013258. https:\/\/doi.org\/10.3341\/kjo.2018.0100","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"6797_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80350-w","volume":"11","author":"S Hwang","year":"2021","unstructured":"Hwang S, Kang SW, Kim KT, Noh H, Kim SJ (2021) Three-year outcomes of vitrectomy combined with intraoperative dexamethasone implantation for non-tractional refractory diabetic macular edema. Sci Rep 11(1):1\u20138. https:\/\/doi.org\/10.1038\/s41598-020-80350-w","journal-title":"Sci Rep"},{"issue":"4","key":"6797_CR71","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00417-023-06299-4","volume":"262","author":"WJ Cho","year":"2024","unstructured":"Cho WJ, Lee JM, Bae HW, Kim CY, Seong GJ, Choi W (2024) Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant. Graefes Arch Clin Exp Ophthalmol 262(4):1231\u20131243. https:\/\/doi.org\/10.1007\/s00417-023-06299-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"6797_CR72","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","volume":"118","author":"JA Haller","year":"2011","unstructured":"Haller JA et al (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118(12):2453\u20132460. https:\/\/doi.org\/10.1016\/j.ophtha.2011.05.014","journal-title":"Ophthalmology"},{"issue":"1","key":"6797_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209997","volume":"14","author":"J Zarranz-Ventura","year":"2019","unstructured":"Zarranz-Ventura J et al (2019) Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world. PLoS One 14(1):e0209997. https:\/\/doi.org\/10.1371\/journal.pone.0209997","journal-title":"PLoS One"},{"key":"6797_CR74","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2147\/OPTH.S80500","volume":"9","author":"W-C Lam","year":"2015","unstructured":"Lam W-C et al (2015) Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol 9:1255\u20131268. https:\/\/doi.org\/10.2147\/OPTH.S80500","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"6797_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00417-016-3431-x","volume":"255","author":"N Eter","year":"2017","unstructured":"Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol 255(1):77\u201387. https:\/\/doi.org\/10.1007\/s00417-016-3431-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"6797_CR76","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ophtha.2013.08.037","volume":"121","author":"P Storey","year":"2014","unstructured":"Storey P et al (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121(1):283\u2013289. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.037","journal-title":"Ophthalmology"},{"issue":"8","key":"6797_CR77","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/bjophthalmol-2015-307707","volume":"100","author":"N Rayess","year":"2016","unstructured":"Rayess N et al (2016) Incidence and clinical features of post-injection endophthalmitis according to diagnosis. Br J Ophthalmol 100(8):1058\u20131061. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307707","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"6797_CR78","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000329863","volume":"226","author":"M Inoue","year":"2011","unstructured":"Inoue M et al (2011) Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica 226(3):145\u2013150. https:\/\/doi.org\/10.1159\/000329863","journal-title":"Ophthalmologica"},{"issue":"1","key":"6797_CR79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5693\/djo.01.2014.07.001","volume":"21","author":"RY Karabag","year":"2015","unstructured":"Karabag RY, Parlak M, Cetin G, Yaman A, Osman Saatci A (2015) Retinal tears and rhegmatogenous retinal detachment after intravitreal injections: its prevalence and case reports. Digit J Ophthalmol 21(1):8\u201310. https:\/\/doi.org\/10.5693\/djo.01.2014.07.001","journal-title":"Digit J Ophthalmol"},{"issue":"5","key":"6797_CR80","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","volume":"24","author":"RD Jager","year":"2004","unstructured":"Jager RD, Aiello LP, Patel SC, Cunningham ETJ (2004) Risks of intravitreous injection: a comprehensive review. Retina 24(5):676\u2013698. https:\/\/doi.org\/10.1097\/00006982-200410000-00002","journal-title":"Retina"},{"issue":"3","key":"6797_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","volume":"21","author":"KM Sampat","year":"2010","unstructured":"Sampat KM, Garg SJ (2010) Complications of intravitreal injections. Curr Opin Ophthalmol 21(3):178\u2013183. https:\/\/doi.org\/10.1097\/ICU.0b013e328338679a","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"6797_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-023-00513-5","volume":"9","author":"P Tsoutsanis","year":"2023","unstructured":"Tsoutsanis P, Kapantais D (2023) Anterior migration of Ozurdex implant: a review on risk factors, complications, and management. Int J Retina Vitreous 9(1):1\u20139. https:\/\/doi.org\/10.1186\/s40942-023-00513-5","journal-title":"Int J Retina Vitreous"},{"key":"6797_CR83","doi-asserted-by":"publisher","unstructured":"Tsoutsanis P, Kapantais D (2023) Anterior migration of Ozurdex implant: a review on risk factors, complications, and management.  https:\/\/doi.org\/10.1186\/s40942-023-00513-5","DOI":"10.1186\/s40942-023-00513-5"},{"issue":"2","key":"6797_CR84","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4274\/TJO.GALENOS.2019.43778","volume":"50","author":"\u00d6 Kay\u0131kc\u0131o\u011flu","year":"2020","unstructured":"Kay\u0131kc\u0131o\u011flu \u00d6, Do\u011fruya S, Sar\u0131g\u00fcl C, Mayal\u0131 H, Kurt E (2020) Anterior chamber migration of Ozurdex implants. Turk J Ophthalmol 50(2):115. https:\/\/doi.org\/10.4274\/TJO.GALENOS.2019.43778","journal-title":"Turk J Ophthalmol"},{"issue":"4","key":"6797_CR85","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1055\/A-0808-1847\/ID\/R0054-4\/BIB","volume":"236","author":"TL Nguyen","year":"2019","unstructured":"Nguyen TL, Wolfensberger TJ (2019) Management of anterior chamber dislocation of a dexamethasone implant. Klin Monbl Augenheilkd 236(4):412\u2013414. https:\/\/doi.org\/10.1055\/A-0808-1847\/ID\/R0054-4\/BIB","journal-title":"Klin Monbl Augenheilkd"},{"issue":"7","key":"6797_CR86","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3928\/23258160-20150730-11","volume":"46","author":"CR Stelton","year":"2015","unstructured":"Stelton CR, Townsend J, Peterson LT, Khurana RN, Yeh S (2015) Surgical management of anterior chamber migration of a dexamethasone intravitreal implant. Ophthalmic Surg Lasers Imaging Retina 46(7):756\u2013759. https:\/\/doi.org\/10.3928\/23258160-20150730-11","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"6797_CR87","doi-asserted-by":"publisher","unstructured":"Ku JY,  Mercieca K,   Yau K (2021) Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula. BMJ Case Rep 14(7). https:\/\/doi.org\/10.1136\/BCR-2020-240504","DOI":"10.1136\/BCR-2020-240504"},{"issue":"3","key":"6797_CR88","doi-asserted-by":"publisher","first-page":"pp","DOI":"10.1007\/s10792-013-9841-4","volume":"34","author":"C Mateo","year":"2014","unstructured":"Mateo C, Alkabes M, Bur\u00e9s-Jelstrup A (2014) Scleral fixation of dexamethasone intravitreal implant (OZURDEX\u00ae) in a case of angle-supported lens implantation. Int Ophthalmol 34(3):pp. https:\/\/doi.org\/10.1007\/s10792-013-9841-4","journal-title":"Int Ophthalmol"},{"issue":"1","key":"6797_CR89","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5301\/ejo.5000317","volume":"24","author":"L Di Antonio","year":"2014","unstructured":"Di Antonio L, Toto L, Carpineto P, Mastropasqua A, De Nicola C, Mastropasqua L (2014) Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion. Eur J Ophthalmol 24(1):134\u2013137. https:\/\/doi.org\/10.5301\/ejo.5000317","journal-title":"Eur J Ophthalmol"},{"key":"6797_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1706234","volume":"2016","author":"L Christensen","year":"2016","unstructured":"Christensen L, Sanders R, Olson J (2016) \u201cMagic Bullet\u201d: eccentric macular hole as a complication from dexamethasone implant insertion. Case Rep Ophthalmol Med 2016:1706234. https:\/\/doi.org\/10.1155\/2016\/1706234","journal-title":"Case Rep Ophthalmol Med"},{"issue":"1","key":"6797_CR91","doi-asserted-by":"publisher","first-page":"NP96","DOI":"10.1177\/11206721231178058","volume":"34","author":"L Landini","year":"2024","unstructured":"Landini L et al (2024) Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage. Eur J Ophthalmol 34(1):NP96\u2013NP99. https:\/\/doi.org\/10.1177\/11206721231178058","journal-title":"Eur J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06797-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:15:54Z","timestamp":1755846954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06797-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6797"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06797-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No Conflicts of Interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"No human participants and\/or animals are involved in this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}